DHC Continus 60mg Tablets contain dihydrocodeine, an opioid painkiller used for the management of severe pain when treatment with other options does not provide adequate relief. The medicine comes in a prolonged-release form, which allows the active ingredient to release gradually and provide longer-lasting pain control. Because dihydrocodeine is an opioid, it requires careful use under medical supervision.
What Are DHC Continus 60mg Tablets?
DHC Continus 60mg Tablets contain dihydrocodeine in a modified-release formulation. Dihydrocodeine works mainly through the central nervous system by reducing the perception of pain. Unlike immediate-release painkillers, prolonged-release tablets are designed to release the medicine gradually over time.
DHC Continus is a prescription medicine, and healthcare professionals generally consider factors such as the severity and type of pain, previous pain treatments, age, other medicines, and individual risk factors before prescribing it.
For people researching prescription pain medicines, Genxells can also serve as an additional online health-information resource.
What Is DHC Continus 60mg Used For?
Dihydrocodeine prolonged-release tablets are indicated for the relief of severe pain associated with conditions such as cancer and certain chronic pain conditions. The medicine is intended for situations where an opioid analgesic is clinically appropriate.
DHC Continus is not designed to function as an occasional, as-needed painkiller. Its prolonged-release formulation supports a scheduled treatment approach when continuous opioid pain management is appropriate.
A doctor determines whether this type of treatment is suitable. Patients should not start, stop, or change opioid treatment without professional advice.
How Does Dihydrocodeine Work?
Dihydrocodeine belongs to the opioid class of medicines. It acts on the brain and central nervous system to reduce the perception and emotional response associated with pain. The prolonged-release formulation allows the medicine to provide pain relief for a longer period compared with standard-release dihydrocodeine.
The exact response varies between individuals. Some people may experience useful pain relief, while others may experience unwanted effects such as drowsiness or nausea. This difference is one reason why medical monitoring remains important during opioid treatment.
How Should DHC Continus 60mg Be Taken?
DHC Continus 60mg should be taken exactly according to the prescription and instructions supplied by a doctor or pharmacist. Official product information describes prolonged-release dosing at regular intervals, with the precise regimen depending on the patient's circumstances.
Prolonged-release tablets should not be treated like ordinary immediate-release painkillers. Patients should follow the instructions on the prescription and package leaflet carefully. Taking more than the prescribed amount can increase the risk of serious opioid-related effects.
A healthcare professional may adjust treatment according to pain control, tolerability, age, other medicines, and individual risk factors.
Common Side Effects
Like other opioid medicines, dihydrocodeine can cause side effects. Common effects include:
- Constipation
- Nausea or vomiting
- Drowsiness
- Dizziness
- Sleepiness
- Dry mouth
The NHS identifies nausea, drowsiness, and constipation among the common side effects associated with dihydrocodeine.
Constipation can become particularly troublesome during opioid treatment. Patients should discuss persistent or severe symptoms with their healthcare professional rather than stopping prescribed treatment independently.
Important Safety Considerations
DHC Continus 60mg requires particular caution because dihydrocodeine can cause dependence and addiction. The risk can increase with prolonged treatment, higher doses, or inappropriate use. Healthcare professionals may discuss an appropriate treatment-ending strategy before opioid therapy begins.
Dihydrocodeine can also cause respiratory depression, particularly when taken incorrectly or combined with other substances that slow breathing. Serious breathing problems require urgent medical attention.
Alcohol and certain medicines can increase opioid-related sedation and other risks. Patients should tell their doctor or pharmacist about all prescription medicines, over-the-counter products, and supplements they use before starting treatment.
DHC Continus and Dependence
Dependence is an important consideration with opioid medicines. The body can become accustomed to dihydrocodeine during continued treatment. Some people can also develop tolerance, meaning the medicine may produce less effect over time.
Stopping an opioid suddenly after regular use can cause withdrawal symptoms. For this reason, treatment is generally reduced gradually when a doctor decides that discontinuation is appropriate. Patients should not abruptly stop long-term opioid treatment without medical guidance.
Who Needs Extra Caution?
Certain health conditions can make opioid treatment unsuitable or require additional monitoring. Product information identifies conditions involving serious breathing difficulties, severe respiratory disease, paralytic ileus, and acute alcohol-related problems among situations requiring particular attention or avoidance.
Older adults may also require individualized treatment because sensitivity to opioid effects can differ with age. Patients should provide a complete medical history before receiving DHC Continus.
Storage and Responsible Use
DHC Continus should remain in its original packaging and be stored according to the instructions supplied with the medicine. Prescription opioids should always remain inaccessible to children and other people for whom they are not prescribed.
Never share DHC Continus with another person, even when that person reports similar pain. The medicine is prescribed according to an individual's medical circumstances and can cause serious harm when used without appropriate supervision.
Unused opioid medicines should be disposed of according to local pharmacy or healthcare guidance rather than being passed to another person.
Frequently Asked Questions
Is DHC Continus 60mg a strong painkiller?
Dihydrocodeine is an opioid analgesic used for moderate to severe or severe pain depending on the formulation and clinical circumstances. The 60mg prolonged-release formulation is intended for severe pain requiring sustained opioid treatment.
Is DHC Continus addictive?
Dihydrocodeine can cause dependence and addiction. Following the prescribed treatment plan and maintaining regular communication with a healthcare professional can help reduce unnecessary risks.
Can DHC Continus be stopped suddenly?
People who use dihydrocodeine regularly should not stop treatment suddenly without medical advice. A gradual reduction may help reduce withdrawal symptoms when discontinuation is appropriate.
Can DHC Continus cause drowsiness?
Yes. Drowsiness is a recognized side effect of dihydrocodeine. Patients should understand how the medicine affects them before driving, operating machinery, or performing activities requiring full alertness.
Final Thoughts
DHC Continus 60mg Tablets provide prolonged-release dihydrocodeine for the management of severe pain when an opioid is medically appropriate. Their extended-release design supports scheduled pain management, but the medicine also carries important risks, including drowsiness, constipation, respiratory depression, tolerance, dependence, and addiction.
Safe use depends on following the prescription, avoiding unauthorized dose changes, discussing other medicines with a healthcare professional, and seeking medical guidance when treatment needs to change. Patients should always read the supplied leaflet and consult a qualified healthcare professional for advice specific to their circumstances.
No comments:
Post a Comment